In summary, osteopontin is a multifaceted modifier, which acts on both the “acute inflammation” features following early muscle damage in dystrophinopathy, and the efficiency of the regenerative process that follows. The gene discussed is SPP1; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.